查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106490

神經發育篩檢解決方案市場預測至2034年－按解決方案類型、篩檢方法、部署模式、年齡層、最終用戶和地區分類的全球分析

Neurodevelopmental Screening Solutions Market Forecasts to 2034 - Global Analysis By Solution Type, Screening Method, Deployment, Age Group, End User, and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球神經發育篩檢解決方案市場預計將在 2026 年達到 46 億美元，並在預測期內以 17.6% 的複合年成長率成長，到 2034 年達到 168 億美元。

神經發育篩檢解決方案是一系列數位化工具和評估平台，旨在識別泛自閉症障礙、注意力不足過動症 (ADHD)、學習障礙、發展遲緩以及言語和語言障礙等神經發育障礙的早期徵兆。這些解決方案利用標準化調查問卷、行為評估、人工智慧、數位生物標記和數據分析，支援早期發現和轉診以進行進一步評估。它們廣泛應用於兒童醫療機構、學校、早期療育計畫和社區醫療機構。人們對早期診斷的日益重視、數位健康技術的進步以及對及時干預需求的不斷成長，正在推動神經發育篩檢解決方案在全球範圍內的普及。

擴大兒童篩檢工作

神經發育篩檢解決方案是一系列數位化和臨床工具，旨在識別發育遲緩、認知障礙和行為障礙。醫療保健專業人員正將常規發展篩檢納入兒童診療流程，以改善早期診斷和治療效果。政府和醫療機構正在擴大以早期發展評估為重點的兒童健康計畫。學校和社區醫療中心也擴大採用標準化篩檢工具。家長和臨床醫生意識的不斷提高持續推動著市場成長。

專家短缺

發育小兒科、兒童心理學家、語言病理學家和其他專科醫生的短缺會導致初次篩檢後的診斷和後續治療延誤。在許多地區，醫療保健系統正面臨著對神經發育評估服務日益成長的需求。雖然數位篩檢技術有助於簡化轉診流程，但它們無法完全取代專科醫生的專業知識。培訓項目正在擴大規模以應對人員短缺問題。遠端醫療服務正在改善服務不足地區獲得專科醫生服務的途徑。然而，專科醫生數量有限仍然限制著及時診斷和乾預。

人工智慧驅動的篩檢技術

人工智慧 (AI) 能夠自動分析行為、發展、語言和認知評估數據，從而加快篩檢。 AI 平台提高了篩檢效率，同時減輕了醫護人員的行政負擔。機器學習的不斷進步正在提高篩檢的準確性。與電子健康記錄的整合正在改善臨床工作流程。技術創新正在擴大早期發育評估的覆蓋範圍。 AI 賦能的篩檢有望為神經發育評估實踐帶來重大變革。

關於病患資料的隱私問題

數位篩檢平台會收集高度敏感的發展、行為和醫療訊息，因此需要採取強力的網路安全措施並遵守醫療資料保護條例。資料安全問題可能會阻礙醫療機構和家庭採用這些平台。平台開發人員正致力於加強加密、身分管理和安全的雲端基礎設施。遵守法規對於維護使用者信任至關重要。持續投資網路安全有助於市場的長期發展。保護患者資訊始終是所有神經發育篩檢解決方案的首要任務。

新型冠狀病毒（COVID-19）的影響：

新冠疫情擾亂了兒童常規就診，限制了醫療服務的可近性，導致許多兒童的發展評估延誤。疫情過後，醫療機構加快了數位篩檢平台、遠端醫療諮詢和遠距發展評估工具的應用，以便及早發現發展問題。人們對兒童發育健康的認知不斷提高，也鼓勵了更多人參與篩檢。醫療系統擴大了數位化兒童醫療服務，以改善醫療服務的可近性。科技在臨床和教育領域的應用仍在加速發展。

在預測期內，篩檢軟體領域預計將佔據最大的市場佔有率。

預計在預測期內，篩檢軟體領域將佔據最大的市場佔有率，因為數位化篩檢平台能夠提供標準化的評估、高效的數據管理和自動評分功能。醫療機構正擴大採用軟體解決方案來提高篩檢的一致性並減少人工管理工作。雲端平台提高了醫院、診所和教育機構的存取便利性。持續的軟體創新正在增強臨床決策支援能力。數位化醫療的日益普及將繼續推動該領域的成長。篩檢軟體仍將是市場中的領先產品類別。

預計在預測期內，嬰幼兒市場將呈現最高的複合年成長率。

在預測期內，由於人們越來越重視嬰幼兒早期發展評估，因此預計嬰幼兒市場將呈現最高的成長率。早期介入措施能夠產生最大的長期效果。小兒科指南擴大建議在嬰幼兒健康檢查中進行常規發育篩檢。早期發現有助於採取更有效的行為、教育和治療介入。家長意識的提高促使更多人參與發展篩檢計畫。醫療保健機構也不斷擴大針對不同年齡層的篩檢計畫。在神經發育篩檢解決方案市場中，嬰幼兒預計將成為成長最快的年齡層。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其完善的兒童醫療保健基礎設施。美國透過廣泛的發展篩檢計畫、先進數位醫療技術的應用以及對兒童行為醫學的大力投資，引領著區域市場的發展；而加拿大則持續拓展其早期兒童評估服務和綜合發展護理計劃。醫療保健專業人員的高度認知以及相關的臨床指南，進一步鞏固了該地區的市場領先地位。北美仍將是神經發育篩檢解決方案的最大市場。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於兒童醫療保健計畫的擴展。中國正在加大對兒童醫療保健基礎設施的投資，印度正透過公共衛生計畫加強早期兒童篩檢工作，日本正持續開發數位化兒童評估技術，澳洲則正在初級保健和教育機構中推廣發展篩檢服務。人們對早期診斷意識的提高以及醫療保健服務可近性的改善正在加速全部區域的市場成長。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球神經發育篩檢解決方案市場：依解決方案類型分類

  • 篩檢軟體
  • 篩檢評估工具
  • 數位篩檢平台
  • 整合篩檢解決方案
  • 其他解決方案類型

第6章：全球神經發育篩檢解決方案市場：依篩檢方法分類

  • 使用問卷篩檢
  • 基於觀察的篩檢
  • 電腦輔助篩檢
  • 人工智慧輔助篩檢
  • 其他篩檢方法

第7章 全球神經發育篩檢解決方案市場：依部署方式分類

  • 基於雲端的
  • 現場

第8章：全球神經發育篩檢解決方案市場：按年齡層別分類

  • 嬰兒
  • 嬰兒
  • 孩子們
  • 青春期
  • 其他年齡層

第9章 全球神經發育篩檢解決方案市場：按最終用戶分類

  • 醫院
  • 小兒科診所
  • 診斷中心
  • 教育機構
  • 其他最終用戶

第10章：全球神經發育篩檢解決方案市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Cognoa, Inc.
  • Qbtech AB
  • Pearson plc
  • WPS Publishing
  • Multi-Health Systems Inc.
  • CentralReach, LLC
  • BrainCheck, Inc.
  • CogniFit Ltd.
  • Medtronic plc
  • Koninklijke Philips NV
  • Natus Medical Incorporated
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd.
  • Canon Medical Systems Corporation
Product Code: SMRC38644

According to Stratistics MRC, the Global Neurodevelopmental Screening Solutions Market is accounted for $4.6 billion in 2026 and is expected to reach $16.8 billion by 2034 growing at a CAGR of 17.6% during the forecast period. Neurodevelopmental screening solutions are digital tools and assessment platforms designed to identify early signs of neurodevelopmental conditions such as autism spectrum disorder, ADHD, learning disabilities, developmental delays, and speech or language disorders. These solutions use standardized questionnaires, behavioral assessments, artificial intelligence, digital biomarkers, and data analytics to support early detection and referral for further evaluation. They are widely used in pediatric healthcare, schools, early intervention programs, and community health settings. Growing awareness of early diagnosis, advancements in digital health technologies, and increasing demand for timely intervention are driving the adoption of neurodevelopmental screening solutions globally.

Market Dynamics:

Driver:

Growing pediatric screening initiatives

Neurodevelopmental screening solutions are digital and clinical tools designed to identify developmental delays cognitive conditions behavioral disorders. Healthcare providers are integrating routine developmental screening into pediatric care to improve early diagnosis and treatment outcomes. Governments and healthcare organizations are expanding child health programs focused on early developmental assessment. Schools and community healthcare centers are increasingly adopting standardized screening tools. Greater awareness among parents and clinicians continues supporting market growth.

Restraint:

Limited specialist availability

The shortage of developmental pediatricians child psychologists speech therapists and other specialists can delay diagnostic confirmation and follow-up care after initial screening. Healthcare systems in many regions face increasing demand for neurodevelopmental assessment services. Digital screening technologies help improve referral efficiency but cannot fully replace specialist expertise. Training programs are expanding to address workforce shortages. Telehealth services are improving specialist access in underserved areas. Limited specialist capacity continues to restrict timely diagnosis and intervention.

Opportunity:

AI-assisted screening technologies

Artificial intelligence enables automated analysis of behavioral developmental speech language and cognitive assessment data supporting faster screening. AI-powered platforms improve screening efficiency while reducing administrative burden for healthcare professionals. Continuous advancements in machine learning are enhancing screening accuracy. Integration with digital health records is improving clinical workflows. Technology innovation is expanding access to early developmental assessment. AI-assisted screening is expected to significantly transform neurodevelopmental assessment practices.

Threat:

Privacy concerns over patient data

Digital screening platforms collect sensitive developmental behavioral and medical information requiring robust cybersecurity safeguards and compliance with healthcare data protection regulations. Data security concerns may reduce adoption among healthcare providers and families. Platform developers are strengthening encryption identity management and secure cloud infrastructure. Regulatory compliance remains essential for maintaining user confidence. Continuous investment in cybersecurity supports long-term market development. Protecting patient information remains a critical priority across neurodevelopmental screening solutions.

Covid-19 Impact:

The COVID-19 pandemic disrupted routine pediatric healthcare visits and delayed developmental assessments for many children during periods of restricted clinical access. Following the pandemic healthcare providers accelerated the adoption of digital screening platforms telehealth consultations and remote developmental assessment tools to identify developmental concerns at earlier stages. Increased awareness of childhood developmental health encouraged greater screening participation. Healthcare systems expanded digital pediatric services to improve accessibility. Technology adoption continued accelerating across clinical and educational settings.

The screening software segment is expected to be the largest during the forecast period

The screening software segment is expected to account for the largest market share during the forecast period as digital screening platforms provide standardized assessments efficient data management automated scoring. Healthcare providers are increasingly adopting software solutions to improve screening consistency and reduce manual administrative tasks. Cloud-based platforms enhance accessibility across hospitals clinics and educational institutions. Ongoing software innovation is improving clinical decision support capabilities. Growing digital health adoption continues driving segment expansion. Screening software remains the leading product segment within the market.

The toddlers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the toddlers segment is predicted to witness the highest growth rate due to increasing emphasis on developmental assessment during the earliest years of childhood when intervention delivers the greatest long-term benefits. Pediatric guidelines increasingly recommend routine developmental screening during toddler health visits. Early identification supports more effective behavioral educational and therapeutic interventions. Growing parental awareness is increasing participation in developmental screening programs. Healthcare providers continue expanding age-specific screening initiatives. Toddlers are expected to represent the fastest-growing age group in the neurodevelopmental screening solutions market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to well-established pediatric healthcare infrastructure. The United States leads the regional market through widespread developmental screening programs advanced digital health adoption and strong investment in pediatric behavioral healthcare while Canada continues expanding early childhood assessment services and integrated developmental care initiatives. High awareness among healthcare professionals and supportive clinical guidelines continue strengthening regional market leadership. North America remains the largest market for neurodevelopmental screening solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by expanding child healthcare programs. China is increasing investments in pediatric healthcare infrastructure while India is strengthening early childhood screening initiatives through public health programs. Japan continues advancing digital pediatric assessment technologies and Australia is expanding developmental screening services across primary healthcare and educational settings. Rising awareness of early diagnosis and improving healthcare accessibility are accelerating market growth across the region.

Key players in the market

Some of the key players in Neurodevelopmental Screening Solutions Market include Cognoa, Inc., Qbtech AB, Pearson plc, WPS Publishing, Multi-Health Systems Inc., CentralReach, LLC, BrainCheck, Inc., CogniFit Ltd., Medtronic plc, Koninklijke Philips N.V., Natus Medical Incorporated, GE HealthCare Technologies Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd. and Canon Medical Systems Corporation.

Key Developments:

In May 2025, CentralReach, LLC finalized a major corporate acquisition when it was absorbed by diversified technology conglomerate Roper Technologies, Inc. for a net purchase price of USD 1.65 billion. This landmark transactional merger integrates CentralReach's specialized cloud-native Applied Behavior Analysis (ABA) operational software into Roper's vertical enterprise portfolio, securing long-term capital backing to expand digital electronic health records and outcome analytics for autism care providers.

In April 2025, Qbtech AB executed a global software implementation partnership with digital health provider Legion Health to integrate its remote ADHD assessment tool, QbCheck, natively into virtual care platforms. This clinical deployment combines standardized infrared motion tracking and computerized attention testing to provide telehealth clinicians with objective symptom metrics, maximizing diagnostic accuracy while lowering behavioral health evaluation overhead.

Solution Types Covered:

  • Screening Software
  • Screening Assessment Tools
  • Digital Screening Platforms
  • Integrated Screening Solutions
  • Other Solution Types

Screening Methods Covered:

  • Questionnaire-Based Screening
  • Observation-Based Screening
  • Computer-Assisted Screening
  • AI-Based Screening
  • Other Screening Methods

Deployments Covered:

  • Cloud-Based
  • On-Premise

Age Groups Covered:

  • Infants
  • Toddlers
  • Children
  • Adolescents
  • Other Age Groups

End Users Covered:

  • Hospitals
  • Pediatric Clinics
  • Diagnostic Centers
  • Educational Institutions
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Neurodevelopmental Screening Solutions Market, By Solution Type

  • 5.1 Screening Software
  • 5.2 Screening Assessment Tools
  • 5.3 Digital Screening Platforms
  • 5.4 Integrated Screening Solutions
  • 5.5 Other Solution Types

6 Global Neurodevelopmental Screening Solutions Market, By Screening Method

  • 6.1 Questionnaire-Based Screening
  • 6.2 Observation-Based Screening
  • 6.3 Computer-Assisted Screening
  • 6.4 AI-Based Screening
  • 6.5 Other Screening Methods

7 Global Neurodevelopmental Screening Solutions Market, By Deployment

  • 7.1 Cloud-Based
  • 7.2 On-Premise

8 Global Neurodevelopmental Screening Solutions Market, By Age Group

  • 8.1 Infants
  • 8.2 Toddlers
  • 8.3 Children
  • 8.4 Adolescents
  • 8.5 Other Age Groups

9 Global Neurodevelopmental Screening Solutions Market, By End User

  • 9.1 Hospitals
  • 9.2 Pediatric Clinics
  • 9.3 Diagnostic Centers
  • 9.4 Educational Institutions
  • 9.5 Other End Users

10 Global Neurodevelopmental Screening Solutions Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Cognoa, Inc.
  • 13.2 Qbtech AB
  • 13.3 Pearson plc
  • 13.4 WPS Publishing
  • 13.5 Multi-Health Systems Inc.
  • 13.6 CentralReach, LLC
  • 13.7 BrainCheck, Inc.
  • 13.8 CogniFit Ltd.
  • 13.9 Medtronic plc
  • 13.10 Koninklijke Philips N.V.
  • 13.11 Natus Medical Incorporated
  • 13.12 GE HealthCare Technologies Inc.
  • 13.13 Siemens Healthineers AG
  • 13.14 F. Hoffmann-La Roche Ltd.
  • 13.15 Canon Medical Systems Corporation

List of Tables

  • Table 1 Global Neurodevelopmental Screening Solutions Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurodevelopmental Screening Solutions Market, By Solution Type (2023-2034) ($MN)
  • Table 3 Global Neurodevelopmental Screening Solutions Market, By Screening Software (2023-2034) ($MN)
  • Table 4 Global Neurodevelopmental Screening Solutions Market, By Screening Assessment Tools (2023-2034) ($MN)
  • Table 5 Global Neurodevelopmental Screening Solutions Market, By Digital Screening Platforms (2023-2034) ($MN)
  • Table 6 Global Neurodevelopmental Screening Solutions Market, By Integrated Screening Solutions (2023-2034) ($MN)
  • Table 7 Global Neurodevelopmental Screening Solutions Market, By Other Solution Types (2023-2034) ($MN)
  • Table 8 Global Neurodevelopmental Screening Solutions Market, By Screening Method (2023-2034) ($MN)
  • Table 9 Global Neurodevelopmental Screening Solutions Market, By Questionnaire-Based Screening (2023-2034) ($MN)
  • Table 10 Global Neurodevelopmental Screening Solutions Market, By Observation-Based Screening (2023-2034) ($MN)
  • Table 11 Global Neurodevelopmental Screening Solutions Market, By Computer-Assisted Screening (2023-2034) ($MN)
  • Table 12 Global Neurodevelopmental Screening Solutions Market, By AI-Based Screening (2023-2034) ($MN)
  • Table 13 Global Neurodevelopmental Screening Solutions Market, By Other Screening Methods (2023-2034) ($MN)
  • Table 14 Global Neurodevelopmental Screening Solutions Market, By Deployment (2023-2034) ($MN)
  • Table 15 Global Neurodevelopmental Screening Solutions Market, By Cloud-Based (2023-2034) ($MN)
  • Table 16 Global Neurodevelopmental Screening Solutions Market, By On-Premise (2023-2034) ($MN)
  • Table 17 Global Neurodevelopmental Screening Solutions Market, By Age Group (2023-2034) ($MN)
  • Table 18 Global Neurodevelopmental Screening Solutions Market, By Infants (2023-2034) ($MN)
  • Table 19 Global Neurodevelopmental Screening Solutions Market, By Toddlers (2023-2034) ($MN)
  • Table 20 Global Neurodevelopmental Screening Solutions Market, By Children (2023-2034) ($MN)
  • Table 21 Global Neurodevelopmental Screening Solutions Market, By Adolescents (2023-2034) ($MN)
  • Table 22 Global Neurodevelopmental Screening Solutions Market, By Other Age Groups (2023-2034) ($MN)
  • Table 23 Global Neurodevelopmental Screening Solutions Market, By End User (2023-2034) ($MN)
  • Table 24 Global Neurodevelopmental Screening Solutions Market, By Hospitals (2023-2034) ($MN)
  • Table 25 Global Neurodevelopmental Screening Solutions Market, By Pediatric Clinics (2023-2034) ($MN)
  • Table 26 Global Neurodevelopmental Screening Solutions Market, By Diagnostic Centers (2023-2034) ($MN)
  • Table 27 Global Neurodevelopmental Screening Solutions Market, By Educational Institutions (2023-2034) ($MN)
  • Table 28 Global Neurodevelopmental Screening Solutions Market, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.